temozolomide has been researched along with bafilomycin a1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Germano, IM; Ito, H; Kanzawa, T; Komata, T; Kondo, S; Kondo, Y | 1 |
Bähr, O; Fischer, S; Fulda, S; Harter, PN; Kögel, D; Mittelbronn, M; Paschke, R; Reichert, S; Ronellenfitsch, MW; Steinbach, JP; Thiepold, AL; Weller, M | 1 |
Aghaei, M; Akbari, M; Albokashy, M; Alizadeh, J; Butterfield, Y; Cole, LK; Eftekharpour, E; Ghavami, S; Hatch, GM; Hombach-Klonisch, S; Islam, MI; Kardami, E; Klonisch, T; Koleini, N; Marzban, H; Samiei, E; Shojaei, S; Thliveris, J; Vosoughi, AR; Xu, F | 1 |
3 other study(ies) available for temozolomide and bafilomycin a1
Article | Year |
---|---|
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
Topics: Adenine; Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Glioma; Humans; Macrolides; Microtubule-Associated Proteins; Organelles; Temozolomide | 2004 |
Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Betulinic Acid; Cathepsin B; Cell Death; Cell Hypoxia; Cell Line, Tumor; Dacarbazine; Dipeptides; Glioma; Humans; Macrolides; Neoplasm Proteins; Pentacyclic Triterpenes; Temozolomide; Triterpenes | 2014 |
Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.
Topics: Animals; Autophagosomes; Cell Death; Cell Line, Tumor; Female; Glioblastoma; Humans; Lysosomes; Macrolides; Mice; Simvastatin; Temozolomide; Xenograft Model Antitumor Assays | 2020 |